We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant

17 hedge funds and large institutions have $208K invested in Revelation Biosciences Warrant in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

6% less funds holding

Funds holding: 1817 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

47% less capital invested

Capital invested by funds: $389K → $208K (-$181K)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

REVBW Hedge Fund Activity: Q2 2022 in Review

17 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q2 2022, worth a combined $208K — down 47% from $389K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of REVBW and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.21K. The largest seller was Linden Advisors, cutting an estimated $31.7K.

  • 17 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q2 2022, down from 18 in Q1 2022.
  • Funds reported $208K of Revelation Biosciences Warrant stock for Q2 2022, down 47% quarter-over-quarter.
  • 2 funds opened new Revelation Biosciences Warrant positions in Q2 2022 and 3 closed out, a net change of -1 holder.
  • The largest Revelation Biosciences Warrant buyer in Q2 2022 was Susquehanna International Group, an estimated $1.21K added.
  • The largest Revelation Biosciences Warrant seller in Q2 2022 was Linden Advisors, an estimated $31.7K sold.

Based on aggregated 13F filings for Q2 2022.